CN115490614B - 一种含氰基取代的烯胺合成方法 - Google Patents

一种含氰基取代的烯胺合成方法 Download PDF

Info

Publication number
CN115490614B
CN115490614B CN202211113907.XA CN202211113907A CN115490614B CN 115490614 B CN115490614 B CN 115490614B CN 202211113907 A CN202211113907 A CN 202211113907A CN 115490614 B CN115490614 B CN 115490614B
Authority
CN
China
Prior art keywords
enamine
cyano
synthesis
bipyridine
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202211113907.XA
Other languages
English (en)
Other versions
CN115490614A (zh
Inventor
陆晓雨
刘孜
钮亚琴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chuzhou University
Original Assignee
Chuzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chuzhou University filed Critical Chuzhou University
Priority to CN202211113907.XA priority Critical patent/CN115490614B/zh
Publication of CN115490614A publication Critical patent/CN115490614A/zh
Application granted granted Critical
Publication of CN115490614B publication Critical patent/CN115490614B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J27/00Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
    • B01J27/06Halogens; Compounds thereof
    • B01J27/128Halogens; Compounds thereof with iron group metals or platinum group metals
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1805Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing nitrogen
    • B01J31/181Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine
    • B01J31/1815Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine with more than one complexing nitrogen atom, e.g. bipyridyl, 2-aminopyridine
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J35/00Catalysts, in general, characterised by their form or physical properties
    • B01J35/19Catalysts containing parts with different compositions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/723,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82Metals of the platinum group
    • B01J2531/821Ruthenium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明属于有机合成领域,涉及一种含氰基取代的烯胺的合成方法。以烯胺和环酮肟为原料,在氯化三(2,2‑联吡啶)钌六水合物和溴化镍二乙二醇二甲醚复合物双催化剂条件下,[4,4′‑双(1,1‑二甲基乙基)‑2,2′‑联吡啶]为配体,三乙烯二胺为碱,在可见光照射下,于N,N‑二甲基乙酰胺溶剂中进行反应,得到具有通式(I)的E‑构型氰基取代的烯胺类化合物。该方法第一次实现了以烯胺和环酮肟为原料,高效率、高选择性的合成了含氰基取代的烯胺类化合物反应实例。反应条件温和、官能团兼容性优越。在有机合成和药物合成中有着重要的应用价值。

Description

一种含氰基取代的烯胺合成方法
技术领域
本发明涉及化合物制备,属于有机合成领域。具体涉及含氰基取代的烯胺的合成方法。
背景技术
含氮有机化合物在许多药物分子中是起到药理活性的关键片段。烯胺类化合物在含氮有机化合物中是一类重要的结构片段和中间体。因其可以转化为重要的生物活性分子、药物分子和手性胺类化合物。并且很多生理活性分子中都含有烯胺片段。因此烯胺类化合物的合成在化学及医药科学中有着重要价值(式 1)。
式1.烯胺的重要性
基于烯胺的重要性,近来很多通过β-H官能化方法被报道。另一方面,氰基是重要的有机官能团和有机合成模块。在药物和生理活性分子中,氰基也是广泛存在的官能团。因此氰基的合成在有机合成中有着重要的价值。然而高效率、高选择性合成含末端氰基的烯胺类化合物还未被实现。因此,合成含末端氰基的烯胺化合物在有机合成化学和医药化学中有着重要的价值。
发明内容
针对目前还没有高效率、高选择性合成含氰基的烯胺化合物。本发明使用烯胺和环酮肟类衍生物,高效率的实现了含氰基烯胺的合成方法。为解决上述技术问题,本发明采用如下技术方案:一种含氰基取代的烯胺合成方法,其特征在于:以烯胺和环酮肟为原料,在氯化三(2,2-联吡啶)钌(II)六水合物[Ru(bpy)3Cl2·6H2O]和溴化镍二乙二醇二甲醚复合物(NiBr2·diglyme)双催化剂条件下,[4,4′-双(1,1-二甲基乙基)-2,2′-联吡啶](dtbpy)为配体,三乙烯二胺(DABCO) 为碱,在可见光照射下,于N,N-二甲基乙酰胺溶剂中,按下述反应式进行反应,得到具有通式(I)的E-构型氰基取代的烯胺类化合物:
优选地,所述Ru(bpy)3Cl2·6H2O的物质的量为烯胺的物质的量的5%。
所述NiBr2·diglyme的物质的量为烯胺的物质的量的8%。
所述dtbpy的物质的量为烯胺的物质的量的10%。
所述DABCO的物质的量为烯胺的物质的量的50%。
优选地,环酮肟的物质的量为烯胺的物质的量的2倍。
优选地,反应温度为室温,可见光波长为465nm,反应时间为12h。
该方法第一次实现了以烯胺和环酮肟为原料,高效率、高选择性的合成了含氰基取代的烯胺类化合物反应实例。反应条件温和、官能团兼容性优越。在有机合成和药物合成中有着重要的应用价值。
具体实施方式
下面通过具体实施方式对本发明的技术方案进行做进一步说明:
实施例1,该实施例的反应式如下所示:
(1)在空气下,Ru(bpy)3Cl2·6H2O(5mol%)、NiBr2·diglyme(8mol%)、 DABCO(50mol%)和环丁酮肟(0.4mmol)加入到一个带支管、含有磁子的密封反应管中,反应管抽冲氩气三次。向反应管中加入0.2mmol苯基烯胺和1mL DMAc,塞紧活塞于465nm光照下室温反应12小时。
(2)旋干步骤(1)中所得的有机相中的溶剂,得到粗产物,然后用硅胶柱纯化粗产物。洗脱剂为石油醚和乙酸乙酯混合物,分离收率为82%,产物纯度100%。
实施例2
该实施例的反应式如下所示:
(1)在空气下,Ru(bpy)3Cl2·6H2O(5mol%)、NiBr2·diglyme(8mol%)、 DABCO(50mol%)和环丁酮肟(0.4mmol)加入到一个带支管、含有磁子的密封反应管中,反应管抽冲氩气三次。向反应管中加入0.2mmol3-溴苯基取代的烯胺和1mL DMAc,塞紧活塞于465nm光照下室温反应12小时。
(2)旋干步骤(1)中所得的有机相中的溶剂,得到粗产物,然后用硅胶柱纯化粗产物。洗脱剂为石油醚和乙酸乙酯混合物,分离收率为77%,产物纯度100%。
实施例3
该实施例的反应式如下所示:
(1)在空气下,Ru(bpy)3Cl2·6H2O(5mol%)、NiBr2·diglyme(8mol%)、 DABCO(50mol%)和肟酯(0.4mmol)加入到一个带支管、含有磁子的密封反应管中,反应管抽冲氩气三次。向反应管中加入0.2mmol苯基取代的烯胺和 1mL DMAc,塞紧活塞于465nm光照下室温反应12小时。
(2)旋干步骤(1)中所得的有机相中的溶剂,得到粗产物,然后用硅胶柱纯化粗产物。洗脱剂为石油醚和乙酸乙酯混合物,分离收率为81%,产物纯度100%。
实施例4
该实施例的反应式如下所示:
(1)在空气下,Ru(bpy)3Cl2·6H2O(5mol%)、NiBr2·diglyme(8mol%)、 DABCO(50mol%)和肟酯(0.4mmol)加入到一个带支管、含有磁子的密封反应管中,反应管抽冲氩气三次。向反应管中加入0.2mmol苯基取代的烯胺和 1mL DMAc,塞紧活塞于465nm光照下室温反应12小时。
(2)旋干步骤(1)中所得的有机相中的溶剂,得到粗产物,然后用硅胶柱纯化粗产物。洗脱剂为石油醚和乙酸乙酯混合物,分离收率为80%,产物纯度100%。
实施例5
该实施例的反应式如下所示:
(1)在空气下,Ru(bpy)3Cl2·6H2O(5mol%)、NiBr2·diglyme(8mol%)、 DABCO(50mol%)和肟酯(0.4mmol)加入到一个带支管、含有磁子的密封反应管中,反应管抽冲氩气三次。向反应管中加入0.2mmol苯基取代的烯胺和 1mL DMAc,塞紧活塞于465nm光照下室温反应12小时。
(2)旋干步骤(1)中所得的有机相中的溶剂,得到粗产物,然后用硅胶柱纯化粗产物。洗脱剂为石油醚和乙酸乙酯混合物,分离收率为77%,产物纯度100%。
所用的各物质的量及反应条件同实施例进行实验拓展,以说明本发明的技术方案具有良好的官能团兼容性。
以上已将本发明做一详细说明,以上所述,仅为本发明之较佳实施例而已,当不能限定本申请实施范围,即凡依本申请范围所作均等变化与修饰,皆应仍属本发明涵盖范围。
附图说明
图1为本发明制备的产物3a的核磁共振氢谱;
图2为本发明制备的产物3a的核磁共振碳谱;图3为本发明制备的产物3i的核磁共振氢谱;图4为本发明制备的产物3i的核磁共振碳谱;图5为本发明制备的产物4a的核磁共振氢谱;图6为本发明制备的产物4a的核磁共振碳谱;图7为本发明制备的产物4e的核磁共振氢谱;图8为本发明制备的产物4e的核磁共振碳谱;图9为本发明制备的产物6a的核磁共振氢谱;图10为本发明制备的产物6a的核磁共振碳谱;图11为本发明制备的产物6b的核磁共振氢谱;图12为本发明制备的产物6b的核磁共振碳谱。

Claims (1)

1.一种含氰基取代的烯胺合成方法,其特征在于:以烯胺和环酮肟为原料,在氯化三(2,2-联吡啶)钌(II)六水合物和溴化镍二乙二醇二甲醚复合物双催化剂条件下,[4,4′-双(1,1-二甲基乙基)-2,2′-联吡啶]为配体,三乙烯二胺为碱,在可见光照射下,于N,N-二甲基乙酰胺溶剂中,按下述反应式进行反应,得到E-构型氰基取代的烯胺类化合物:
CN202211113907.XA 2022-09-03 2022-09-03 一种含氰基取代的烯胺合成方法 Active CN115490614B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211113907.XA CN115490614B (zh) 2022-09-03 2022-09-03 一种含氰基取代的烯胺合成方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211113907.XA CN115490614B (zh) 2022-09-03 2022-09-03 一种含氰基取代的烯胺合成方法

Publications (2)

Publication Number Publication Date
CN115490614A CN115490614A (zh) 2022-12-20
CN115490614B true CN115490614B (zh) 2024-04-12

Family

ID=84468022

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211113907.XA Active CN115490614B (zh) 2022-09-03 2022-09-03 一种含氰基取代的烯胺合成方法

Country Status (1)

Country Link
CN (1) CN115490614B (zh)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112262128A (zh) * 2018-05-08 2021-01-22 科罗拉多州立大学研究基金会 用光照形成芳基碳-氮键的方法和用于进行该反应的光反应器
CN113563224A (zh) * 2020-12-31 2021-10-29 滁州学院 一种含γ-氰基三取代烯烃的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200147581A1 (en) * 2018-05-08 2020-05-14 Colorado State University Research Foundation Methods for forming aryl carbon-nitrogen bonds using light and photoreactors useful for conducting such reactions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112262128A (zh) * 2018-05-08 2021-01-22 科罗拉多州立大学研究基金会 用光照形成芳基碳-氮键的方法和用于进行该反应的光反应器
CN113563224A (zh) * 2020-12-31 2021-10-29 滁州学院 一种含γ-氰基三取代烯烃的合成方法

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Photoredox-catalyzed regio- & stereoselective C(sp2)–H cyanoalkylation of enamides with cycloketone oximes via selective C–C bond cleavage/radical addition cascade;Ting Guan,等;Green Chem.(第24期);第6525页左栏第2段、右栏Table 1 *
Visible-Light-Promoted Selenocyanation of Cyclobutanone Oxime Esters Using Potassium Selenocyanate;Xia Zhao,等;J. Org. Chem.;第86卷(第17期);第11399页左栏第3段第1-7行、右栏Scheme 1,第11400页左栏Table 1 *
脂肪腈的合成方法及规模化制备进展;徐宝华;王耀锋;丁光荣;丁其达;徐晓峰;饶崇顺;张锁江;;中国科学:化学(第07期);第42-81页 *
铁催化硝基烯烃与环丁酮肟酯还原脱硝基交叉偶联反应研究;吴泽锋;昆明理工大学硕士学位论文;全文 *
铜催化N―O键断裂策略研究进展;雷禄;李承璟;莫冬亮;;有机化学(第11期);第 17-40页 *

Also Published As

Publication number Publication date
CN115490614A (zh) 2022-12-20

Similar Documents

Publication Publication Date Title
CN101812026B (zh) 一种硼替佐米的合成方法
CN115490614B (zh) 一种含氰基取代的烯胺合成方法
CN112321487A (zh) 一种多取代异吲哚啉化合物及其制备方法
CN109939737B (zh) 卡宾钴催化剂、其制备方法及其在催化氢化醛和酮化合物中的应用
CN114853759B (zh) 一种氮杂环化苝酰亚胺的制备方法
CN114853658B (zh) 一种9-(4-溴苯基)咔唑的合成方法
CN116496316A (zh) 一种氟烯基磷的合成方法
CN114349609B (zh) 一种六苯并蔻二聚体的合成方法
CN114957170B (zh) 一种醚类化合物邻位碳-氢键直接单氟烯基化反应
CN107973715B (zh) 一种多取代远端烯丙基酮衍生物的制备方法
CN112521289B (zh) 一种氧杂烯丙基胺类化合物及其制备方法和应用
CN110938086B (zh) 半夹心钌硫酮配合物及其制备方法、氨硼烷的水解方法和硝基苯类化合物的还原方法
CN113831510B (zh) 一种基于苯并硒二唑的共价有机框架及其制备方法与应用
CN112608208B (zh) 一种室温条件脱羧制备γ-氰基烯烃的合成方法
CN114105821B (zh) 一种七氟异丁腈的制备方法
WO2003055844A1 (en) Process for preparing terbinafine and hci salt thereof
CN116041220B (zh) 一种芳基取代的酰胺类化合物的制备方法
CN114349610B (zh) 一种含双[6]螺旋结构的六苯并蔻二聚体的合成方法
CN111377963B (zh) 一种可见光促进的脱氢偶联反应制备硫代膦化合物的方法
CN116986969A (zh) 一种氟代烯丙醇的合成方法
CN112441921B (zh) 一种铱光催化合成9-乙酰氧基-9,10-二氢菲类化合物的方法
CN112441874B (zh) 一种铱光催化合成9-三氟甲基-9,10-二氢菲类化合物的方法
KR100296942B1 (ko) (1.1.1.1)페드란화합물
CN112047809A (zh) 一种含有氟原子的醇类化合物的制备方法
CN118771952A (zh) 一种三氟甲基取代的氟烯烃合成方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant